BCSCs with CD44+/CD24−/low and ALDH1 phenotypes isolated from different subtypes of breast cancer, based on molecular profiling of receptor expression (estrogen receptor, progesterone receptor, or human epidermal growth factor receptor 2), have similar gene expression profiles [72]. This evidence concerns the gene CD44 and breast cancer.